Private Capital Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $5K | Sell |
171
-8
| -4% | -$234 | ﹤0.01% | 1248 |
|
|
2022
Q1 | $7K | Buy |
179
+150
| +517% | +$5.87K | ﹤0.01% | 1385 |
|
|
2021
Q4 | $1K | Sell |
29
-230
| -89% | -$7.93K | ﹤0.01% | 1920 |
|
|
2021
Q3 | $13K | Sell |
259
-340
| -57% | -$17.1K | ﹤0.01% | 1248 |
|
|
2021
Q2 | $38K | Sell |
599
-1,122
| -65% | -$71.2K | 0.01% | 784 |
|
|
2021
Q1 | $160K | Sell |
1,721
-189
| -10% | -$17.6K | 0.04% | 254 |
|
|
2020
Q4 | $171K | Buy |
1,910
+195
| +11% | +$17.5K | 0.03% | 346 |
|
|
2020
Q3 | $177K | Sell |
1,715
-350
| -17% | -$36.1K | 0.04% | 303 |
|
|
2020
Q2 | $163K | Sell |
2,065
-291
| -12% | -$23K | 0.04% | 314 |
|
|
2020
Q1 | $136K | Sell |
2,356
-94
| -4% | -$5.43K | 0.04% | 335 |
|
|
2019
Q4 | $132K | Buy |
2,450
+296
| +14% | +$15.9K | 0.03% | 370 |
|
|
2019
Q3 | $113K | Sell |
2,154
-243
| -10% | -$12.7K | 0.02% | 442 |
|
|
2019
Q2 | $121K | Buy |
2,397
+239
| +11% | +$12.1K | 0.03% | 331 |
|
|
2019
Q1 | $109K | Sell |
2,158
-101
| -4% | -$5.1K | 0.02% | 436 |
|
|
2018
Q4 | $134K | Buy |
2,259
+41
| +2% | +$2.43K | 0.03% | 310 |
|
|
2018
Q3 | $146K | Sell |
2,218
-179
| -7% | -$11.8K | 0.03% | 323 |
|
|
2018
Q2 | $121K | Buy |
2,397
+647
| +37% | +$32.7K | 0.03% | 356 |
|
|
2018
Q1 | $92K | Buy |
1,750
+1,676
| +2,265% | +$88.1K | 0.02% | 437 |
|
|
2017
Q4 | $1 | Buy |
+74
| New | +$1 | ﹤0.01% | 1926 |
|